Penetration of Topically Administered 0.5-Percent Caspofungin Eye Drops into Human Aqueous Humor
Authors:
- Chin Fen NeohCNChin Fen Neoh
- Lok LeungLLLok Leung
- Anant MisraAMAnant Misra
- Rasik B. VajpayeeRVRasik B. Vajpayee
- Geoffrey E. DaviesGDGeoffrey E. Davies
- Robert O. FullinfawRFRobert O. Fullinfaw
- Kay StewartKSKay Stewart
- David C. M. KongDKDavid C. M. Kong
- 1 April 2011
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (4) , 1761-1763
Abstract
Ten participants attending elective anterior segment eye surgery received 0.5% caspofungin eye drops either 1 drop hourly for 4 h or 1 drop an hour before surgery. The eye drops were generally well tolerated. In the absence of inflammation or corneal abrasion, topical caspofungin does not achieve clinically relevant concentrations.Keywords
This publication has 24 references indexed in Scilit:
- Rapid and Sensitive Liquid Chromatography/Mass Spectrometry Assay for Caspofungin in Human Aqueous HumorAntimicrobial Agents and Chemotherapy, 2010
- Intraocular caspofungin: in vitro safety profile for human ocular cellsMycoses, 2010
- Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitisJournal of Antimicrobial Chemotherapy, 2009
- Aqueous Humor Concentrations of Topically Administered Caspofungin in RabbitsOphthalmic Research, 2008
- Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapyBMC Infectious Diseases, 2007
- Fungal keratitis in MelbourneClinical & Experimental Ophthalmology, 2007
- Topical Caspofungin for Treatment of Keratitis Caused by Candida albicans in a Rabbit ModelAntimicrobial Agents and Chemotherapy, 2005
- High Diversity of Group A Streptococcal emm Types in an Indian Community: The Need to Tailor Multivalent VaccinesClinical Infectious Diseases, 2005
- Fungal keratitisCurrent Opinion in Ophthalmology, 2004
- Pharmacotherapy of fungal eye infectionsExpert Opinion on Pharmacotherapy, 2001